TY - JOUR
T1 - Precursor T-cell acute lymphoblastic leukemia in adults
T2 - Age-related immunophenotypic, cytogenetic, and molecular subsets
AU - Onciu, Mihaela
AU - Lai, Raymond
AU - Vega, Francisco
AU - Bueso-Ramos, Carlos
AU - Medeiros, L. Jeffrey
PY - 2002
Y1 - 2002
N2 - We analyzed the clinicopathologic and molecular findings in 26 adults (age 16-72 years) with T-cell acute lymphoblastic leukemia (T-ALL) and observed features that correlated with age. Patients older than 60 years (n = 5) had a low frequency of hepatosplenomegaly (0 [0%]), anterior mediastinal mass (1 [20%]), and lymphadenopathy (2 [40%]), and completely responded to chemotherapy (4 of 4). The T-ALL in this group commonly expressed myeloid antigens (4 [80%]), had lineage-inappropriate gene rearrangements (2/3 [67%]) and chromosome 2 deletion (3/4 [75%]), and exclusively used the VIII, or VIVfamilies of the T-cell receptor (TCR) gamma gene. In comparison, patients 16 to 60 years old (n = 21) more commonly had an anterior mediastinal mass (8 [38%]), hepatosplenomegaly (10 [48%]), and lymphadenopathy (16 [76%]). The tumors in these patients commonly used the TCR gamma gene VI or VII families (17/25 total rearrangements [68%]). Myeloid antigen expression (5 [24%]) and lineage inappropriate gene rearrangements (4/15 [27%]) were uncommon. Within this group, CD1a expression correlated with age 28 to 60 years. These results illustrate considerable age-related heterogeneity in adult T-ALL, which may reflect differences in tumor cell maturation.
AB - We analyzed the clinicopathologic and molecular findings in 26 adults (age 16-72 years) with T-cell acute lymphoblastic leukemia (T-ALL) and observed features that correlated with age. Patients older than 60 years (n = 5) had a low frequency of hepatosplenomegaly (0 [0%]), anterior mediastinal mass (1 [20%]), and lymphadenopathy (2 [40%]), and completely responded to chemotherapy (4 of 4). The T-ALL in this group commonly expressed myeloid antigens (4 [80%]), had lineage-inappropriate gene rearrangements (2/3 [67%]) and chromosome 2 deletion (3/4 [75%]), and exclusively used the VIII, or VIVfamilies of the T-cell receptor (TCR) gamma gene. In comparison, patients 16 to 60 years old (n = 21) more commonly had an anterior mediastinal mass (8 [38%]), hepatosplenomegaly (10 [48%]), and lymphadenopathy (16 [76%]). The tumors in these patients commonly used the TCR gamma gene VI or VII families (17/25 total rearrangements [68%]). Myeloid antigen expression (5 [24%]) and lineage inappropriate gene rearrangements (4/15 [27%]) were uncommon. Within this group, CD1a expression correlated with age 28 to 60 years. These results illustrate considerable age-related heterogeneity in adult T-ALL, which may reflect differences in tumor cell maturation.
KW - Adults
KW - Cytogenetics
KW - Immunophenotype
KW - Molecular studies
KW - T-cell acute lymphoblastic leukemia
UR - http://www.scopus.com/inward/record.url?scp=0036329038&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036329038&partnerID=8YFLogxK
U2 - 10.1309/08DJ-GPBH-H0VR-RC6F
DO - 10.1309/08DJ-GPBH-H0VR-RC6F
M3 - Article
C2 - 11863221
AN - SCOPUS:0036329038
SN - 0002-9173
VL - 117
SP - 252
EP - 258
JO - American journal of clinical pathology
JF - American journal of clinical pathology
IS - 2
ER -